Related Experiment Videos

Markedly delayed postoperative malignant hyperthermia

Insights

Delayed malignant hyperthermia (MH) can occur hours after anesthesia. Early recognition and dantrolene sodium treatment are crucial for managing this rare but serious condition in surgical patients.

Area of Science:

  • Anesthesiology
  • Pharmacology

Background:

  • Malignant hyperthermia (MH) is a rare, hypermetabolic crisis often triggered by volatile anesthetics and succinylcholine.
  • While typically occurring during anesthesia, delayed-onset MH (1-4 hours postoperatively) has been reported in isolated cases.

Observation:

  • This report details a case of delayed-onset malignant hyperthermia occurring 11 hours after a routine tonsillectomy and adenoidectomy.
  • The patient presented with tachypnea, tachycardia, hyperthermia, and metabolic acidosis, indicative of MH.

Findings:

  • Intravenous administration of dantrolene sodium proved therapeutic for the delayed-onset MH.
  • Serial serum creatine phosphokinase levels confirmed the diagnosis of malignant hyperthermia.

Implications:

  • This case highlights the potential for significant delays in MH onset, extending beyond the typical postoperative window.
  • Emphasizes the critical need for vigilance and prompt diagnosis of MH in the postoperative period.
  • Underscores the importance of thorough preoperative screening for individuals with a potential susceptibility to malignant hyperthermia.

Related Concept Videos